HER2/EBBR2 Cancer Research Results
HER2/EBBR2, Human epidermal growth factor receptor 2: Click to Expand ⟱
| Source: |
| Type: |
Also called erbB-2 (or ERb-2) -Receptor tyrosine-protein kinase
HER2 is a protein that helps breast cancer cells grow quickly.
HER2/neu protein is a receptor tyrosine kinase that is normally involved in cell growth and division. However, in some cancers, the HER2/neu gene is overexpressed or mutated, leading to an overproduction of the protein. This can cause cells to grow and divide uncontrollably, leading to tumor formation.
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
Apoptosis↑, TumCG↓, TumCI↓, TumMeta↓, glucoNG↓, ChemoSen↑, TumCCA↑, Casp3↑, Casp7↑, cl‑PARP↑, survivin↓, EGFR↓, HER2/EBBR2↓, ATP↓, Glycolysis↓, mt-OXPHOS↓, AKT1↓, HK2↓, Hif1a↓, ROS↑, NRF2↑, EMT↓, COX2↓, MMP2↓, MMP9↓, Zeb1↓, Snail↓, HDAC↓, HATs↓, MMP↓, Cyt‑c↓, Shh↓, Smo↓, Gli1↓, BioAv↝, BioAv↝, Dose↝,
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
NRF2↑, 2, mt-OXPHOS↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, MMP↓, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AKT1↓, 1, glucoNG↓, 1, Glycolysis↓, 1, HK2↓, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↑, 1, Bax:Bcl2↑, 1, Casp3↑, 2, Casp7↑, 1, Casp8∅, 1, Casp9↑, 1, Cyt‑c↓, 1, Cyt‑c↑, 1, DR5↑, 1, survivin↓, 1, TRAIL↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
HER2/EBBR2↓, 2, p70S6↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
HATs↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
cl‑PARP↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
p19↑, 1, P21↑, 1, TumCCA?, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CD44↓, 1, CSCs↓, 1, EMT↓, 1, Gli1↓, 1, HDAC↓, 2, p‑mTOR↓, 1, Shh↓, 1, Smo↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
MMP2↓, 1, MMP9↓, 1, Snail↓, 1, TumCI↓, 1, TumMeta↓, 1, Zeb1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 2, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 2, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 2, ChemoSen↑, 2, Dose↝, 1, eff↓, 2,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 2, GutMicro↝, 1, HER2/EBBR2↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, TumW↓, 2,
Total Targets: 59
Pathway results for Effect on Normal Cells:
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: HER2/EBBR2, Human epidermal growth factor receptor 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:359 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page